The rising prevalence of Aspergillosis, combined with favourable government regulations, is driving the expansion of the Aspergillosis treatment market. According to a study published in the Journal of Fungi in 2016, CPA is predicted to afflict almost three million individuals worldwide, making it a major health problem that causes mortality and morbidity. Antifungal and corticosteroid medications can be used to treat Aspergillosis infection. Corticosteroid medications are used to treat allergic bronchopulmonary aspergillosis. These medications reduce inflammation and alleviate respiratory symptoms including coughing and wheezing.
Methylprednisolone, prednisolone, and prednisone are some of the most commonly used medications. The Food and Drug Administration (FDA) of the United States has approved many medications for the treatment of Aspergillosis infection. For example, in 2015, the US Food and Drug Administration approved Isavuconazonium (Astellas Pharma), a prodrug version of Isavuconazole.
Read More:
https://knackersblogger.blogspot.com/2022/10/aspergillosis-treatment-market-global.html
